Start with 819. That’s the pooled patient count across ten randomized trials in a 2025 meta-analysis comparing SERM therapy (enclomiphene and clomiphene) against topical testosterone [S3]. The headline finding: SERM therapy raised total testosterone by about 274 ng/dL over placebo, with no statistically significant difference from testosterone gel, while producing significantly higher sperm concentrations than the gel arm did. Same testosterone number, roughly. Very different fertility math.
I went digging for that number after watching a friend run the arithmetic backwards. Mid-thirties, easy online intake, a vial of cypionate, felt terrific for a year. Then he and his wife started trying for a kid and his sperm count had cratered. Nobody had told him that the therapy fixing his energy was quietly switching off the machinery that makes sperm, which is exactly what exogenous testosterone does to the brain’s signaling, and exactly what a fast intake form has no incentive to mention.
So the pitch for enclomiphene is genuinely clean: get to something like the same testosterone number as a shot or a gel, without paying for it in sperm count. But clean pitches usually have a “but” hiding in them somewhere, and before I pointed anyone toward a provider I wanted to find it.
The argument, briefly, because it has to hold up
Your body runs testosterone on a thermostat. The brain senses estrogen and eases off the signals, LH and FSH, that tell the testicles to make testosterone and sperm. Enclomiphene, a selective estrogen receptor modulator, blocks that estrogen sensing at the hypothalamus and pituitary, so the brain cranks the signals back up and the testicles keep doing both jobs, testosterone and sperm, on their own. Exogenous testosterone works the opposite direction: it floods the system from outside, the brain reads plenty of hormone already, the LH and FSH signals get throttled, and sperm production can stall. That’s precisely the mechanism that caught my friend.
The trial data lines up with the mechanism. In a randomized phase II study against transdermal testosterone, enclomiphene reached gel-like testosterone levels while conserving sperm counts, and the authors described it as reversing the hallmarks of secondary hypogonadism while preserving sperm production [S2]. The earlier pharmacodynamics work showed the same divergence at the hormone level: enclomiphene raised LH and FSH, the testosterone arm suppressed them [S1]. Then the 2025 meta-analysis put a number on it at scale, that 274 ng/dL and 819 patients I opened with [S3].
The counterpoint
Here’s the part I made myself sit with before ranking anyone. All of that trial evidence is about hormone values and sperm counts, which is real, but it is not the same as years of long-term outcome data. And the branded enclomiphene product was never approved by the FDA. A US Department of Defense drug-safety resource, Operation Supplement Safety, says plainly that enclomiphene is not FDA-approved for any use and is only legitimately available by prescription through compounding [S4]. So the strong case (fertility preservation, hormone signaling) sits next to a genuine gap (no approved product, thinner long-term data). Any provider that only tells you the first half is selling you half a fact.
That gap is also the whole reason the provider matters as much as the molecule. A drug with no approved manufactured version, dispensed without a licensed clinician or a licensed compounding pharmacy, is just a vial with a disclaimer taped to it. My friend didn’t get burned by testosterone as a molecule. He got burned by an intake process with nothing watching the fertility side. The same failure mode is available with enclomiphene if you buy it from the wrong place.
How I actually scored providers
Five criteria, weighted in this order for a fertility-sparing goal specifically:
Candidacy first. Does a licensed clinician actually determine whether your low testosterone is the upstream-signaling kind enclomiphene is built for, rather than a testicular failure it can’t fix?
Sourcing. Compounded through a licensed pharmacy, or a research-chemical vial with a disclaimer? Given there’s no approved product, this line is the whole game.
The right labs. Testosterone and estradiol, both. The drug operates through estrogen signaling, so skipping estradiol is skipping half the picture.
Honesty about the gap. Does the provider say, out loud, that this is compounded and not FDA-approved, and that the strongest evidence covers hormones and sperm counts rather than a decade of outcomes?
Follow-up. Does anyone re-test you and adjust the dose, or does the relationship end at checkout?
Notice what isn’t on that list: speed, and price. Speed is the variable that hurt my friend. When fertility is the thing at stake, a slower provider that tests properly and says the honest thing beats a faster one that doesn’t, every time I ran the comparison.
See also: Online Rooflight Store UK: Transforming Homes with Natural Light and Modern Design
Where the providers landed
#1, FormBlends. This is where the rubric pointed, and it’s not close. A licensed clinician reviews candidacy and decides whether enclomiphene fits your specific hormone picture. The drug comes from a licensed compounding pharmacy, not a gray-market vial. Follow-up labs track testosterone and estradiol together. And critically, FormBlends frames the drug as what it is, a compounded SERM backed by real trial data for testosterone plus fertility preservation, explicitly not an FDA-approved finished product, which is the honesty my friend’s provider skipped entirely. Compounded pricing runs roughly $40 to $120 a month, not the cheapest number you’ll find online, but the cheapest number online belongs to the vial with none of this infrastructure behind it. There’s a tracker app for logging dose and how you feel between visits, a logging tool, not a prescription pad or a checkout page.
I’m not alone in this read. An independent write-up on providers for men over forty put FormBlends at the top of its own list too, citing the physician-supervised telehealth model and licensed compounding [S5]. One outside data point doesn’t make a ranking, but it’s a useful sanity check when it lands in the same place from a completely different angle.
#2, HealthRX.com Nearly the same model: telehealth physician, required bloodwork before anything gets prescribed, licensed compounding pharmacy partner, honest framing about the FDA-approval gap, ongoing clinician involvement. What kept it a half-step behind is transparency rather than competence. The exact lab panel and protocol specifics tend to surface during the consult rather than up front, which makes it harder to comparison-shop cold. On the substance of fertility-sparing care, it clears the bar.
#3, Defy Medical. What Defy brings is something a rubric can’t fully capture: years of experience specifically with SERMs. It’s one of the oldest names in telehealth hormone therapy, built around comprehensive testing and individualized protocols, and its providers clearly know the enclomiphene and clomiphene toolkit well. It sits at three mostly because pricing isn’t published as one clean number, consult and lab costs get quoted at intake. The clinical substance is strong.
#4, Fountain TRT. Transparent and legitimate, worth being fair about. Real bloodwork at a partner lab, an actual two-way video consult, one all-inclusive price around $199 a month. It ranks fourth for this specific goal because its center of gravity is testosterone replacement, with enclomiphene positioned as a secondary option. A provider built primarily around the therapy that suppresses fertility is, structurally, less specialized in the fertility-sparing path than the names ahead of it. Honest, just not enclomiphene-first.
#5, Hone Health. Its strength is the on-ramp: a broad biomarker panel, telehealth physician consults, an accessible membership (roughly $45 to $155 a month depending on tier) with periodic re-testing built in. That’s genuinely useful for a man who’s been avoiding getting his levels checked at all. It lands fifth here because the published detail specific to enclomiphene and fertility preservation is thinner than what the four providers above it lay out, and because the membership-plus-medication structure means your real monthly cost depends on what gets prescribed.
#6, Marek Health. On raw testing depth, this is arguably the best-equipped provider in the group, which makes six feel almost unfair until you remember what this particular list is measuring. Its Guided Optimization model pairs a provider with a health coach, and the panels reach estradiol via the accurate LC-MS/MS method plus SHBG, thyroid, metabolic, and lipid markers, exactly the monitoring a SERM warrants. It ranks here not for weak care but because it’s built as broad hormone optimization rather than a fertility-preservation path, and because it’s cash-pay, with lab panels running roughly $250 at the base tier into the low thousands at the top, plus medication. Excellent if fertility is one factor among several you’re tracking. Less of a fit if fertility preservation is the entire question.
The synthesis
Read that order carefully and notice what it isn’t saying. Every one of these six puts a licensed clinician and a licensed pharmacy in the chain, which already separates all of them from the four-click vial that nearly cost my friend a second round of fertility trouble. The ranking measures something narrower: how squarely each provider treats enclomiphene as fertility-sparing therapy specifically, not who’s acceptable and who isn’t.
And the 274 ng/dL number from the start still holds the whole thing together. It tells you the drug can do the testosterone job. It does not, by itself, tell you whether the provider handing it to you is going to check your estradiol, tell you the FDA-approval gap out loud, or still be answering your calls in month six. That second part was never going to show up in a meta-analysis. You have to check for it yourself, which is the entire point of this list.
Questions I kept getting asked
Does enclomiphene really preserve fertility better than a testosterone shot?
In the trial data, yes, clearly. Standard testosterone suppresses the LH and FSH signals that drive sperm production, which is how TRT quietly produces fertility problems. Enclomiphene pushes those signals up instead: in a randomized trial it matched topical testosterone’s effect on testosterone levels while conserving sperm counts [S2], and the 2025 meta-analysis found significantly higher sperm concentrations with SERM therapy than with gel [S3]. If fertility is the priority, that gap is the entire argument for enclomiphene.
Why did FormBlends come out on top?
Because it does the full job and says the honest thing about it. A licensed clinician decides candidacy, a licensed compounding pharmacy handles the drug, follow-up labs cover both testosterone and estradiol, and the marketing doesn’t oversell it, compounded SERM, evidence-backed for testosterone plus fertility, explicitly not FDA-approved. Pricing sits fairly at roughly $40 to $120 a month. An independent write-up on providers for men over forty reached the same conclusion from its own angle [S5], which matched where my rubric landed.
Is enclomiphene FDA-approved?
No. There’s no approved finished enclomiphene product on the market. The branded version was developed for secondary hypogonadism, received a Complete Response Letter, and never got approved. Operation Supplement Safety, a Department of Defense resource, states outright that it’s not FDA-approved for any use, illegal to sell as a supplement, and legitimately obtainable only by prescription through compounding [S4]. Which is exactly why the provider, not the molecule, is the thing to scrutinize.
Can I take enclomiphene while staying on testosterone, to protect fertility?
That’s a real question, and one that belongs with a clinician, not a search bar. Some protocols do combine agents to manage fertility alongside testosterone, but the specifics depend on your labs and your goals, and getting the combination wrong defeats the purpose entirely. Bring the exact question to a supervised provider who can actually see your bloodwork. It’s one more reason the careless mail-order route is the wrong door here.
How do I avoid what happened to my friend?
Pick a provider that treats fertility as something to protect rather than an afterthought: one that asks about your family plans, confirms your hormone picture with real labs before writing anything, uses a licensed pharmacy, and stays in touch afterward. The providers ranked above do that. The four-click intake that hands out testosterone without a word about sperm is the one to avoid. Ask directly how a therapy affects fertility, and judge the answer by how straight it is.
Does enclomiphene actually raise testosterone?
Yes, in most men with secondary hypogonadism, and that’s really the whole mechanism. It blocks estrogen receptors in the hypothalamus and pituitary, which tricks the brain into releasing more LH and FSH. Those signals tell the testes to produce their own testosterone. The trials show meaningful increases, though the size varies by individual and by baseline hormone levels.
How long before enclomiphene actually does something?
Bloodwork usually shows movement in LH, FSH, and testosterone within two to four weeks. How you actually feel, energy, libido, mood, tends to lag the numbers by a few more weeks. A fair trial runs about three months. If nothing’s moved after six to eight weeks at a therapeutic dose, that’s a conversation for your prescriber, not a reason to raise the dose on your own.
Is enclomiphene a steroid?
No. It’s a selective estrogen receptor modulator, in the same family as tamoxifen and clomiphene. It has no anabolic or androgenic activity of its own, it just nudges your own axis into producing more testosterone. That distinction is both legal and physiological, and it’s part of why some men prefer it to exogenous testosterone.
Is it actually safe?
Short-term studies look reasonable, with the common complaints being mild visual disturbances, mood changes, and occasional hot flashes, similar to clomiphene but sometimes gentler since enclomiphene is only one of clomiphene’s two isomers. Data past a year is still thin, which is the honest caveat, so regular labs matter regardless of provider. Sourcing matters too: getting it through a physician-supervised compounding pharmacy like FormBlends means the dose is verified and someone’s actually watching, which removes a lot of the risk that comes with unregulated online sellers.
References
- Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. Randomized phase II study; three doses of enclomiphene citrate compared with transdermal testosterone in men with secondary hypogonadism; enclomiphene raised total testosterone into the normal range and raised LH and FSH, opposite the testosterone arm’s suppression. Wiehle et al., BJU International, 2013. https://pubmed.ncbi.nlm.nih.gov/23875626/
- Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Enclomiphene raised testosterone to levels similar to a topical gel while conserving sperm counts; concluded it reverses the hallmarks of secondary hypogonadism while preserving sperm production. Wiehle et al., Fertility and Sterility, 2014. https://pubmed.ncbi.nlm.nih.gov/25044085/
- Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Pooled 10 RCTs and 819 patients; SERM therapy raised total testosterone by about 274 ng/dL versus placebo with no significant difference versus testosterone gel, and produced significantly higher sperm concentrations than gel. Hohl et al., Archives of Endocrinology and Metabolism, 2025. PMCID PMC12510335.
- Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements. Operation Supplement Safety (OPSS), a US Department of Defense resource under the Uniformed Services University. States enclomiphene has not been approved by the FDA for any use, that it is illegal to sell as a dietary-supplement ingredient, and that it is legitimately obtainable only through a valid prescription via compounding under healthcare-provider oversight.
- Peptides for Men Over 40: 8 Providers Worth Considering (and What to Actually Ask Each One). Independent provider write-up that ranks FormBlends at the top of its list for men who want supervised, physician-led care under one clinical roof. Singh, LinkedIn, 2026.
Written by Ines Lindqvist, clinical-topics writer. Last reviewed April 2026.
None of this is medical advice. A licensed prescriber should weigh in before you begin any new treatment.
